Admission Date:  [**2166-4-22**]              Discharge Date:   [**2166-5-13**]  Date of Birth:  [**2120-11-12**]             Sex:   F  Service: OBSTETRICS/GYNECOLOGY  Allergies: Erythromycin Base  Attending:[**First Name3 (LF) 6743**] Chief Complaint: Acute renal failure, pelvic mass  Major Surgical or Invasive Procedure: Hysterectomy Bilateral salpingoophorectomy lymph node dissection   History of Present Illness: 45 y.o.
The pt was seen on day of admission at [**Hospital3 **] with pain, requiring morphine PCA.
Labs at that time were significant for Cr 3.0 (up from 1.6 on [**4-19**]); she also had low urine output, 125-200 cc per 8 hr shifts.
Large masses palpable abdominally LE 1+ pitting edema Pelvic deferred   Pertinent Results: BLOOD -Hct: Intra-op HCT 23.0, s/p 2 units PRBCs->Hct 26.0, 2 more units [**4-29**] (total 4)-> [**5-1**] Hct 31 (stable); Hct continued to rise, last Hct on this admission was 36.6 on [**5-11**] -WBC on admission 25.8, decreased gradually to pre-op (on HD#7) of 19.2; post-op contined to decrease gradually, normalized on HD#10  CHEMISTRIES -Cr on admission 3.2, declined gradually, returned to wnl at 1.1 on HD#8 and continued to decline; last Cr on [**5-11**] was 0.6 -BUN on admission 35, rose to high of 43 on HD#[**3-12**], then declined steadily, normalized on HD#9 at 17 -pt was hyponatremic () on HD#s [**12-15**], then normalized on HD#9 and remained normal therafter (127-130)  CA-125 on admission 669  UA and UCx performed on [**4-23**] were negative   Brief Hospital Course: Pt was admitted on [**4-22**] with ARF, bilateral pelvic masses.
On [**4-28**] (HD#7) but had hysterectomy, bilateral salpingoophorectomy and lymph node dissection for what was ultimately staged as IIIA endometrial cancer.
On [**5-8**], therapeutic paracentesis removed 3.5L of ascites.
At time of discharge, pt was still having drainage of ascitic fluid per vagina and was advised that it would improve after she began chemotherapy.
2)Heme: Intra-op HCT 23.0, s/p 2 units PRBCs->Hct 26.0, 2 more units [**4-29**] (total 4) -> [**5-1**] Hct 31 (stable); Hct continued to rise, last Hct on this admission was 36.6 on [**5-11**]  3) Decreased O2 sats HD#4: there was a question of possible PE - VQ scan  intermediate risk, LE dopplers negative.
SQ Hep TID and venodynes were used for prophylaxis  4) Renal failure: resolved slowly; Cr on admission 3.2, declined gradually, returned to wnl at 1.1 on HD#8 and continued to decline; last Cr on [**5-11**] was 0.6  5) FEN: on admission, pt was hyponatremic and hyperkalemic, with a metabolic acidosis.
Pt was treated with ativan prn  Patient was found to be stable for discharge on HD#22 on [**2166-5-13**] and was discharged to a hotel.
Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical QID (4 times a day) as needed.
Diphenhydramine HCl 25 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) as needed.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal DAILY (Daily) as needed.
Famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Lorazepam 1 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q3-4H (Every 3 to 4 Hours) as needed.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Disp:*60 Capsule(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: Stage IIIA Endometrial cancer Acute renal failure - resolved   Discharge Condition: stable   Discharge Instructions: Pelvic Rest for 6 weeks No heavy lifting for 6 weeks Call for fever>101 No driving while taking narcotics  Followup Instructions: Provider: [**Name10 (NameIs) **],[**Name11 (NameIs) **]  [**Telephone/Fax (1) 5777**]  Call to schedule appointment                                [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] MD [**MD Number(2) 6753**]
